Name | PERVOURAL'SKOE MUNITSIPAL'NOE UNITARNOE PREDPRIYATIE "APTEKA N458" |
|---|
INN | 6625002059 |
|---|
KPP | 668401001 |
|---|
OGRN | 1026601503092 |
|---|
OKPO | 20881103 |
|---|
Address | 623104, Sverdlovskaya Oblast', g. Pervoural'sk, ul. Komsomol'skaya, d. D.15 A |
|---|
Phone | 2-09-40 Contact details |
|---|
Fax | 2-09-30 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores |
Registration date | 01.10.2002 |
|---|
Registering department | Administratsiya goroda Pervoural'ska |
|---|
|
PMUP "APTEKA N458" (Sverdlovsk Oblast; INN 6625002059) was registered on 1 Oct 2002. The company's authorized capital as of July 1, 2012 was 2250 rub. Type of ownership of PMUP "APTEKA N458" - Unitary enterprises based on the principle of economic management. Form of ownership of PMUP "APTEKA N458" - Municipal property. Principal activities of PMUP "APTEKA N458": retailing drugs in specialized stores (pharmacies) (47.73), retailing products used for medical purposes, orthopedic goods in specialized stores (47.74). |
Economic indicators2023
Net profit (RAS) of PMUP APTEKA N458 grew over 2023 by 13.22% to 1.70 million RUB from 1.51 million RUB over 2022, the company informed. Revenue decreased in the accounting period by 6.06% to 107.97 million RUB from 114.93 million RUB in 2022; cost of goods sold decreased by 8.25% to 81.81 million RUB from 89.17 million RUB; sales profit went up by 6.15% to 3.26 million RUB from 3.07 million RUB. 2022
Net profit (RAS) of PMUP APTEKA N458 grew over 2022 by 32.48% to 1.51 million RUB from 1.14 million RUB over 2021, the company informed. Revenue increased in the accounting period by 18.39% to 114.93 million RUB from 97.08 million RUB over 2021; cost of goods sold grew by 18.57% to 89.17 million RUB from 75.20 million RUB; sales profit went up by 28.14% to 3.07 million RUB from 2.40 million RUB. 2021
Net profit (RAS) of PMUP APTEKA N458 grew over 2021 by 28.94% to 1.14 million RUB from 881.00 thousand RUB over 2020, the company informed. Revenue increased in the accounting period by 4.88% to 97.08 million RUB from 92.56 million RUB over 2020; cost of goods sold grew by 4.03% to 94.68 million RUB from 91.01 million RUB; sales profit went up 1.55 times to 2.40 million RUB from 1.55 million RUB. 2020
Net profit (RAS) of PMUP APTEKA N458 grew over 2020 by 8.50% to 881.00 thousand RUB from 812.00 thousand RUB over 2019, the company informed. Revenue remained in the accounting period at the same level and made up 92.56 million RUB compared to 92.43 million RUB 92.43 million RUB; cost of goods sold remained at the same level amounting to 91.01 million RUB compared to 90.79 million RUB; sales profit fell by 5.49% to 1.55 million RUB from 1.64 million RUB. 2019
Net profit (RAS) of PMUP APTEKA N458 grew over 2019 by 13.73% to 812.00 thousand RUB from 714.00 thousand RUB over 2018, the company informed. Revenue increased in the accounting period by 10.49% to 92.43 million RUB from 83.65 million RUB over 2018; cost of goods sold grew by 41.20% to 90.79 million RUB from 64.30 million RUB; sales profit went up by 24.85% to 1.64 million RUB from 1.31 million RUB. 2018
Net profit (RAS) of PMUP APTEKA N458 grew over 2018 by 0.85% to 714.00 thousand RUB from 708.00 thousand RUB over 2017, the company informed. Revenue increased in the accounting period by 1.67% to 83.65 million RUB from 82.28 million RUB over 2017; cost of goods sold grew by 1.68% to 64.30 million RUB from 63.24 million RUB; sales profit fell by 15.08% to 1.31 million RUB from 1.55 million RUB. 2017
Net profit (RAS) of PMUP APTEKA N458 dropped in 2017 by 8.87% to 709.00 thousand RUB from 778.00 thousand RUB over the same period in 2016, the company informed. Revenue decreased in the accounting period by 4.09% to 82.28 million RUB from 85.79 million RUB in 2016; cost of goods sold decreased by 4.98% to 63.24 million RUB from 66.56 million RUB; sales profit went up by 6.04% to 1.55 million RUB from 1.46 million RUB. 2016
Net profit (RAS) of PMUP APTEKA N458 grew over 2016 by 49.33% to 778.00 thousand RUB from 521.00 thousand RUB over 2015, the company informed. Revenue decreased in the accounting period by 0.83% to 85.79 million RUB from 86.51 million RUB in 2015; cost of goods sold decreased by 1.36% to 66.56 million RUB from 67.48 million RUB; sales profit matched the previous year’s result amounting to 1.46 million RUB. 2014
Net profit (RAS) of PMUP APTEKA N 458 dropped in 2014 2.64 times to 375.00 thousand RUB from 989.00 thousand RUB over the same period in 2013, the company informed. Revenue decreased in the accounting period by 4.72% to 88.50 million RUB from 92.88 million RUB in 2013; cost of goods sold decreased by 2.74% to 68.26 million RUB from 70.19 million RUB; sales profit fell by 29.55% to 1.59 million RUB from 2.25 million RUB. 2013
Net profit (RAS) of PMUP APTEKA N 458 grew over 2013 1.81 times to 989.00 thousand RUB from 547.00 thousand RUB over 2012, the company informed. Revenue increased in the accounting period by 4.73% to 92.88 million RUB from 88.68 million RUB over 2012; cost of goods sold grew by 4.89% to 70.19 million RUB from 66.91 million RUB; sales profit went up by 2.97% to 2.25 million RUB from 2.19 million RUB. 2012
Net profit (RAS) of PMUP Apteka 458 grew over 2012 by 47.04% to 547.00 thousand RUB from 372.00 thousand RUB over 2011, the company informed. Cost of goods sold grew by 11.19% to 66.91 million RUB from 60.18 million RUB; sales profit went up by 21.21% to 2.19 million RUB from 1.81 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|